What reporters should know about drug recalls, the FDA and drug manufacturing risks
How to participate
Note: This webcast is for AHCJ members, so you will need to have your login and password to participate. If you don't have that, please visit this page and enter your email address to have an access key sent to you.
A link to the webcast will be posted here about 15 minutes before it begins.
» Please use this diagnostic test page to be sure you're set up correctly to enter the webcast.
Jan. 24, 1 p.m. ET
Millions of Americans are taking prescription drugs made in China and don’t know it – and pharmaceutical companies are not eager to tell them. The pressure to lower costs has led some drug companies to look overseas where manufacturing standards are less strict and quality control can be iffy. This poses particular risks to older adults, who often take a half-dozen or more medications daily and who may be especially vulnerable to devastating side effects from tainted products.
Rosemary Gibson, author, “China Rx: Exposing the risks of America's dependence on China for medicine;” senior adviser, The Hastings Center; Section Editor, Less is More in JAMA Internal Medicine.
Moderator: Liz Seegert
Rosemary Gibson writes and lectures about health care, health care reform, Medicare, and patient safety. She is a senior advisor at The Hastings Center, and section editor for Less is More in JAMA Internal Medicine. Previously, she led national health care quality and safety initiatives at the Robert Wood Johnson Foundation. In 2014, Gibson received the highest honor from American Medical Writers Association for outstanding contributions to reporting on critical health issues in the public interest.